Sexually Transmitted Infections

The best way to protect yourself and others from STIs is to get regularly tested. Why take the risk?

Learn More

Sexually transmitted infections (STIs) are a global health concern causing millions of infections each year and billions in healthcare cost.

There are 500,000 new STI infections globally and 1 in 5 people in the US have an STI.

The most common STIs are chlamydia, gonorrhea, trichomoniasis, hepatitis, genital herpes, HIV, HPV, mycoplasma and syphilis.

Untreated STIs can lead to severe health problems in men and women, such as reproductive health problems, pelvic inflammatory disease, ectopic pregnancy, preterm birth, and infertility.

Most people who have chlamydia, gonorrhea or trichomonas do not have symptoms. Rapid diagnosis and screening can improve treatment, reduce complications and reduce the transmission of STIs.

Sexually Transmitted Infection Targets


Chlamydia is the most frequently reported bacterial STI in US, caused by Chlamydia trachomatis.
CDC estimated about 4 million chlamydia infections in 2018 (US). Most people who have chlamydia do not have symptoms.


Gonorrhea is the second most reported bacterial STI in US, caused by Neisseria gonorrhoeae.
CDC estimated about 1,6 million new gonorrhea infections in 2018 (US). Most people who have chlamydia do not have symptoms.


Trichomoniasis is a common curable STI, caused by Trichomonas vaginalis. CDC estimates that there were more than 2 million trichomonas infections in 2018.
Most people who have cannot tell they have it, only 30% is symptomatic. It is a commonly missed infection in woman.


Mycoplasma is an STI caused by Mycoplasma genitalium. Can cause discharge, burning and/or pain during urination, vaginal pain, bleeding.
Mycoplasma is an often under recognized STI, it is more common in Europe than US, but in some states the prevalence is higher than Gonorrhea.

Genital Herpes

Herpes is a common STI that can be caused by Herpes simplex virus type 1 and Herpes simplex virus type 2 and is the leading cause of genital ulcer disease. More than 12% of 14-49yr old are infected with genital herpes in US. Genital herpes is a chronic, lifelong viral infection.
There is no cure for genital herpes. Medicine can reduce symptoms and the chance of spreading it to others.
Diagnosing STIs at POC

There are limited tools available at the point of care (POC) to screen for and diagnose STIs fast and accurately.

Molecular PCR is the golden standard for diagnosis but is usually performed in the central lab with up to 5 days turnaround time. Patients often get empirically treated before the lab results come in or patients may be lost to follow up. This can cause mistreatment, discomfort for the patients, insecurities, and further spreading of STIs, without realizing.


The miDiagnosticsTM HSV-1&2 Swab Test (coming soon) is intended to detect the presence of Herpes simplex virus 1 and 2 in lesion swabs collected from symptomatic patients using an easy-to-use compact PCR system at the POC.

For professional use.

Our HSV 1&2 Swab Test is open for co-development partnerships. Reach out at to discuss, or contact us here.

Accurate results in less than 20 minutes.

  • Immediate access to the right treatment
  • Alleviate discomfort
  • Improve self-confidence
  • Avoid misdiagnosis
  • Eliminate recurrent doctor’s visits
  • Reduce severe complications
  • Stop spreading STIs
How it works

How it works.

Swab Sample

For use with swabs.

PCR Card

A small volume of the sample (5µl) is placed on the disposable PCR Card containing the silicon chip.

PCR Reader

The multiple use, portable reader performs the temperature cycling and optical detection, processes data and communicates the test result.

Key Benefits.


Unique silicon chip technology allowing for ultra-fast PCR


Built-in controls ensure the highest quality result


Easy-to-use touchscreen with intuitive user-interface and built-in scanning technology


Closed reaction chamber limits risk of contamination and cross-infection


Sends reports directly to laboratory/POC information systems, or network printer


Platform compatible with various tests


If you are interested in further information as we get closer to launching our miDiagnosticsTM HSV-1&2 Swab Test or our miDiagnosticsTM STI Test please contact